http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022098800-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03aad55c17f7d74bbe435ede3a748377
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-163
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B3-113
filingDate 2021-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bb63f086a1573b20ca573aacc01f7e7
publicationDate 2022-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022098800-A1
titleOfInvention Assessing and treating eye contact aversion and impaired gaze
abstract Provided for may be a system for assessing an eye contact aversion bias comprising initiating a first predetermined number of trials, wherein a trial comprises generating a displayed human face having a first spatial location corresponding to a first feature and a second spatial location corresponding to a second feature, wherein the first feature is the eyes of the displayed human face, and the second feature is not the eyes of the displayed human face, generating a target stimulus, wherein the target stimulus is presented at the first or the second spatial location, and receiving a selection signal. The system may further comprise calculating a response time, a first average response time, a second average response time, and calculating the eye contact aversion bias.
priorityDate 2020-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012172304-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007032410-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10363192-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6010
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408624

Total number of triples: 22.